Søgeresultater - Torsten Tonn

Refine Results
  1. 1
    Natural Killer Cells for Therapy of Leukemia

    Natural Killer Cells for Therapy of Leukemia af Garnet Suck, Yeh Ching Linn, Torsten Tonn

    Udgivet 2016
    Få fuldtekst Få fuldtekst
    Revisão
    Føj til favoritter
    Saved in:
  2. 2
    Epitopes of MUC1 Tandem Repeats in Cancer as Revealed by Antibody Crystallography: Toward Glycopeptide Signature-Guided Therapy

    Epitopes of MUC1 Tandem Repeats in Cancer as Revealed by Antibody Crystallography: Toward Glycopeptide Signature-Guided Therapy af Dapeng Zhou, Lan Xu, Wei Huang, Torsten Tonn

    Udgivet 2018
    Få fuldtekst Få fuldtekst
    Revisão
    Føj til favoritter
    Saved in:
  3. 3
    Bone-marrow-derived progenitor cell therapy in need of proof of concept: design of the REPAIR-AMI trial

    Bone-marrow-derived progenitor cell therapy in need of proof of concept: design of the REPAIR-AMI trial af Volker Schächinger, Torsten Tonn, Stefanie Dimmeler, Andreas M. Zeiher

    Udgivet 2006
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  4. 4
    Transfusion of Packed Red Cells

    Transfusion of Packed Red Cells af Markus Müller, Christof Geisen, Kai Zacharowski, Torsten Tonn, Erhard Seifried

    Udgivet 2015
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  5. 5
    Cell isolation procedures matter: a comparison of different isolation protocols of bone marrow mononuclear cells used for cell therapy in patients with acute myocardial infarction

    Cell isolation procedures matter: a comparison of different isolation protocols of bone marrow mononuclear cells used for cell therapy in patients with acute myocardial infarction af Florian Seeger, Torsten Tonn, N. Krzossok, Andreas M. Zeiher, Stefanie Dimmeler

    Udgivet 2007
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  6. 6
    NK-92: an ‘off-the-shelf therapeutic’ for adoptive natural killer cell-based cancer immunotherapy

    NK-92: an ‘off-the-shelf therapeutic’ for adoptive natural killer cell-based cancer immunotherapy af Garnet Suck, Marcus Odendahl, Paulina Nowakowska, Christian Seidl, Winfried S. Wels, Hans Klingemann, Torsten Tonn

    Udgivet 2015
    Få fuldtekst
    Revisão
    Føj til favoritter
    Saved in:
  7. 7
    Chimeric Antigen Receptor-Engineered NK-92 Cells: An Off-the-Shelf Cellular Therapeutic for Targeted Elimination of Cancer Cells and Induction of Protective Antitumor Immunity

    Chimeric Antigen Receptor-Engineered NK-92 Cells: An Off-the-Shelf Cellular Therapeutic for Targeted Elimination of Cancer Cells and Induction of Protective Antitumor Immunity af Congcong Zhang, Pranav Oberoi, Sarah Oelsner, Anja Waldmann, Aline Lindner, Torsten Tonn, Winfried S. Wels

    Udgivet 2017
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  8. 8
    Retargeting of natural killer–cell cytolytic activity to ErbB2-expressing cancer cells results in efficient and selective tumor cell destruction

    Retargeting of natural killer–cell cytolytic activity to ErbB2-expressing cancer cells results in efficient and selective tumor cell destruction af Christoph Uherek, Torsten Tonn, Barbara Uherek, Sven Becker, Barbara S. Schnierle, Hans-Georg Klingemann, Winfried S. Wels

    Udgivet 2002
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  9. 9
    Mechanisms of resistance to natural killer cell-mediated cytotoxicity in acute lymphoblastic leukemia

    Mechanisms of resistance to natural killer cell-mediated cytotoxicity in acute lymphoblastic leukemia af A Romański, Gesine Bug, Sven Becker, Manuela Kampfmann, Erhard Seifried, Dieter Hoelzer, Oliver G. Ottmann, Torsten Tonn

    Udgivet 2005
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  10. 10
    <scp>CD</scp>19‐<scp>CAR</scp> engineered <scp>NK</scp>‐92 cells are sufficient to overcome <scp>NK</scp> cell resistance in B‐cell malignancies

    <scp>CD</scp>19‐<scp>CAR</scp> engineered <scp>NK</scp>‐92 cells are sufficient to overcome <scp>NK</scp> cell resistance in B‐cell malignancies af A Romański, Christoph Uherek, Gesine Bug, Erhard Seifried, Hans Klingemann, Winfried S. Wels, Oliver G. Ottmann, Torsten Tonn

    Udgivet 2016
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  11. 11
    Expression of a CD20-specific chimeric antigen receptor enhances cytotoxic activity of NK cells and overcomes NK-resistance of lymphoma and leukemia cells

    Expression of a CD20-specific chimeric antigen receptor enhances cytotoxic activity of NK cells and overcomes NK-resistance of lymphoma and leukemia cells af Tina Müller, Christoph Uherek, Guitta Maki, Kai Uwe Chow, Annemarie Schimpf, Hans-Georg Klingemann, Torsten Tonn, Winfried S. Wels

    Udgivet 2007
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  12. 12
    Clinical grade manufacturing of genetically modified, CAR-expressing NK-92 cells for the treatment of ErbB2-positive malignancies

    Clinical grade manufacturing of genetically modified, CAR-expressing NK-92 cells for the treatment of ErbB2-positive malignancies af Paulina Nowakowska, A Romański, Nicole Miller, Marcus Odendahl, Halvard Bönig, Congcong Zhang, Erhard Seifried, Winfried S. Wels, Torsten Tonn

    Udgivet 2017
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  13. 13
    PROMOTER CHOICE: THE IDEAL PROMOTER TO DRIVE CHIMERIC ANTIGEN RECEPTOR (CAR) EXPRESSION IN NK CELLS

    PROMOTER CHOICE: THE IDEAL PROMOTER TO DRIVE CHIMERIC ANTIGEN RECEPTOR (CAR) EXPRESSION IN NK CELLS af RN Silvestre, Jiří Eitler, JTC Azevedo, K.C. Malmegrim, Kamilla Swiech, Dimas Tadeu Covas, Torsten Tonn, Virgínia Picanço‐Castro

    Udgivet 2021
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  14. 14
    CAR-Engineered NK Cells for the Treatment of Glioblastoma: Turning Innate Effectors Into Precision Tools for Cancer Immunotherapy

    CAR-Engineered NK Cells for the Treatment of Glioblastoma: Turning Innate Effectors Into Precision Tools for Cancer Immunotherapy af Michael C. Burger, Congcong Zhang, Patrick N. Harter, A Romański, F Straßheimer, Christian Senft, Torsten Tonn, Joachim P. Steinbach, Winfried S. Wels

    Udgivet 2019
    Få fuldtekst Få fuldtekst
    Revisão
    Føj til favoritter
    Saved in:
  15. 15
    Transcoronary Transplantation of Functionally Competent BMCs Is Associated With a Decrease in Natriuretic Peptide Serum Levels and Improved Survival of Patients With Chronic Postinfarction Heart Failure

    Transcoronary Transplantation of Functionally Competent BMCs Is Associated With a Decrease in Natriuretic Peptide Serum Levels and Improved Survival of Patients With Chronic Postin... af Birgit Aßmus, Ulrich Fischer‐Rasokat, Jörg Honold, Florian Seeger, Stephan Fichtlscherer, Torsten Tonn, Erhard Seifried, Volker Schächinger, Stefanie Dimmeler, Andreas M. Zeiher

    Udgivet 2007
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  16. 16
    Comparison of potency assays to assess SARS-CoV-2 neutralizing antibody capacity in COVID-19 convalescent plasma

    Comparison of potency assays to assess SARS-CoV-2 neutralizing antibody capacity in COVID-19 convalescent plasma af Christine von Rhein, Tatjana Scholz, Lisa Henß, Romy Kronstein‐Wiedemann, Tatjana Schwarz, Roman N. Rodionov, Victor M. Corman, Torsten Tonn, Barbara S. Schnierle

    Udgivet 2020
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  17. 17
    Improved Human Erythropoiesis and Platelet Formation in Humanized NSGW41 Mice

    Improved Human Erythropoiesis and Platelet Formation in Humanized NSGW41 Mice af Susann Rahmig, Romy Kronstein‐Wiedemann, Juliane Fohgrub, Nicole Kronstein, Aleksandra Nevmerzhitskaya, Martin Bornhäuser, Max Gassmann, Alexander Platz, Rainer Ordemann, Torsten Tonn, Claudia Waskow

    Udgivet 2016
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  18. 18
    ENGINEERED CD19-CAR NK CELLS AS AN OFF-THE-SHELF ALTERNATIVE TO B CELL LEUKEMIA AND LYMPHOMA TREATMENT

    ENGINEERED CD19-CAR NK CELLS AS AN OFF-THE-SHELF ALTERNATIVE TO B CELL LEUKEMIA AND LYMPHOMA TREATMENT af Renata Nacasaki Silvestre, Jiří Eitler, Daianne Maciely Carvalho Fantacini, Kelen Cristina Ribeiro Malmegrim, Kamilla Swiech, Dimas Tadeu Covas, Torsten Tonn, Virgínia Picanço‐Castro

    Udgivet 2020
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  19. 19
    Continuously expanding CAR NK-92 cells display selective cytotoxicity against B-cell leukemia and lymphoma

    Continuously expanding CAR NK-92 cells display selective cytotoxicity against B-cell leukemia and lymphoma af Sarah Oelsner, Miriam E. Friede, Congcong Zhang, Juliane Wagner, Susanne Badura, Peter Bader, Evelyn Ullrich, Oliver G. Ottmann, Hans Klingemann, Torsten Tonn, Winfried S. Wels

    Udgivet 2016
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  20. 20
    A Pilot Trial to Assess Potential Effects of Selective Intracoronary Bone Marrow–Derived Progenitor Cell Infusion in Patients With Nonischemic Dilated Cardiomyopathy

    A Pilot Trial to Assess Potential Effects of Selective Intracoronary Bone Marrow–Derived Progenitor Cell Infusion in Patients With Nonischemic Dilated Cardiomyopathy af Ulrich Fischer‐Rasokat, Birgit Aßmus, Florian Seeger, Jörg Honold, David M. Leistner, Stephan Fichtlscherer, Volker Schächinger, Torsten Tonn, Hans Martin, Stefanie Dimmeler, Andreas M. Zeiher

    Udgivet 2009
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:

Søgeredskaber: